Search results
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes· 1 day agoUntil now the biosimilars have gained minimal traction. The number of new prescriptions written for...
How to Get Prescription Weight Loss Medication Without Insurance
MediaFeed via AOL· 1 day agoWhether you’re on a weight loss journey of your own or not, you probably haven’t been able to avoid...
Mariposa County Drug Take Back Day on Saturday, April 27, 2024
Sierra Sun Times· 7 days agoMariposa County Drug Take Back Day on Saturday, April 27, 2024
Mavenclad and cost: Reducing long-term drug costs and more
Medical News Today· 18 hours agoMavenclad (cladribine) is a brand-name oral tablet that’s prescribed for certain types of multiple...
Justice Dept plans to reschedule marijuana as a lower-risk drug
KEYT 3 Santa Barbara· 2 days agoThe US Department of Justice recommended that marijuana be rescheduled as a Schedule III controlled...
Cost and Jaypirca: Financial assistance options, savings, more
Medical News Today· 2 days agoThe cost of the drug can depend on several factors, such as whether Jaypirca has a savings program....
Map shows where millions could lose Medicare Advantage benefits
Newsweek· 9 hours agoAfter Humana announced it would be cutting its Medicare Advantage plans by 2025, seniors have been panicked, wondering how it will affect their health care coverage. Six million Americans are ...
At least 25,000 people in the US are starting weight-loss drug Wegovy each week, drugmaker says
CNN via Yahoo Finance· 14 hours agoDrugmaker Novo Nordisk said it’s been increasing supply of its sought-after weight-loss drug Wegovy,...
Yervoy cost 2024: Coupons and more
Medical News Today· 2 days agoYervoy (ipilimumab) is a brand-name solution for intravenous injection. It’s prescribed for certain types of cancer, including melanoma, kidney cancer,...
Novo sees Wegovy sales dip on lower price, tight supply
BioPharma Dive via Yahoo Finance· 17 hours agoLilly is facing similar pressure with Zepbound. The company is undertaking “the most ambitious...